Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Contrast Media

October 21, 2015 — Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and Medicaid ...

Home October 21, 2015
Home
BRAVO 3 trial results, bivalirudin, heparin, anticoagulation, TAVR, TCT 2015
Feature | Antiplatelet and Anticoagulation Therapies

October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding ...

Home October 20, 2015
Home
Amaranth Fortitute Bioresorbable stent
Feature | TCT | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline

There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual ...

Home October 19, 2015
Home
FFR-CT, cost and quality of life outcomes, TCT 2015, PLATFORM trial
Feature | CT Angiography (CTA)

October 18, 2015 — New results from a multicenter, prospective study show that assessing fractional flow reserve ...

Home October 18, 2015
Home
RESPECT trial, long-term study results, TCT 2015, PFO closure, recurrent cryptogenic stroke
Feature | Stroke

October 16, 2015 — Long-term study results from the RESPECT trial found that closing a patent foramen ovale (PFO) with ...

Home October 16, 2015
Home
Claret embolic protection, TAVR, cerebral protection
Feature | Heart Valve Technology

October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at ...

Home October 16, 2015
Home
News | Heart Valve Technology

October 15, 2015 — Edwards Lifesciences Corp. announced that details on the 13 first-in-human compassionate use cases wi ...

Home October 15, 2015
Home
PARTNER II Trial, TCT 2015, Edwards Lifesciences, Sapien 3 valve, one-year results
Feature | Heart Valve Technology

October 15, 2015 — One-year patient outcomes from the PARTNER II trial showed the low rate of 30-day complications with ...

Home October 15, 2015
Home
Technology | Heart Valve Technology

October 15, 2015 — U.S. Food and Drug Administration (FDA) has cleared Edwards Lifesciences Sapien XT transcatheter ...

Home October 15, 2015
Home
News

October 14, 2015 — AtriCure Inc. announced it has entered into a definitive merger agreement under which AtriCure has ...

Home October 14, 2015
Home
News | Heart Valve Technology

October 14, 2015 — Boston Scientific Corp. announced it has closed on an additional round of financing with MValve ...

Home October 14, 2015
Home
News | CT Angiography (CTA)

October 8, 2015 — Oregon Health & Science University (OHSU) now offers patients one of the most advanced computed ...

Home October 08, 2015
Home
Technology | Cath Lab

October 8, 2015 — Shimadzu Medical Systems USA announced the availability of the MIX package for the Trinias ...

Home October 08, 2015
Home
CMS, Stage 3 Meaningful Use final rule, ONC, healthcare IT, electronic health records, EHR
Feature | Information Technology

October 7, 2015 — The Centers for Medicare and Medicaid Services (CMS) released the final version of Stage 3 Meaningful ...

Home October 07, 2015
Home
Subscribe Now